Welcome to this special edition of the IP Think Tank podcast for Monday the 18th of May 2009. In this call Duncan speaks to Gregory Glover, a panellist at the 2009 BIO International Convention about the pending Biosimilar legislation and concerns over situations where a follow on product might avoid patent claims but still be able to rely on innovator regulatory data.
We hope you enjoy this show, and as always, we look forward to your comments and feedback.
Links:
The 2009 BIO International Convention – http://convention.bio.org
The Panel session ‘Biotech Intellectual Property at the Crossroads’ – http://convention.bio.org/templates/default_page_template.aspx?id=1415
Gregory Glover – http://www.pharmalawgrp.com/biography.html
